- Home
- CRTO vs SLNO Comparison
CRTO vs SLNO Comparison
Compare CRTO & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRTO
- SLNO
- Stock Information
- Founded
- CRTO 2005
- SLNO 1999
- Country
- CRTO France
- SLNO United States
- Employees
- CRTO N/A
- SLNO N/A
- Industry
- CRTO Advertising
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CRTO Consumer Discretionary
- SLNO Health Care
- Exchange
- CRTO Nasdaq
- SLNO Nasdaq
- Market Cap
- CRTO 2.1B
- SLNO 2.3B
- IPO Year
- CRTO 2013
- SLNO 2014
- Fundamental
- Price
- CRTO $35.02
- SLNO $71.99
- Analyst Decision
- CRTO Buy
- SLNO Strong Buy
- Analyst Count
- CRTO 10
- SLNO 8
- Target Price
- CRTO $54.67
- SLNO $92.00
- AVG Volume (30 Days)
- CRTO 331.9K
- SLNO 1.8M
- Earning Date
- CRTO 05-01-2025
- SLNO 05-08-2025
- Dividend Yield
- CRTO N/A
- SLNO N/A
- EPS Growth
- CRTO 115.91
- SLNO N/A
- EPS
- CRTO 1.90
- SLNO N/A
- Revenue
- CRTO $1,933,289,000.00
- SLNO N/A
- Revenue This Year
- CRTO N/A
- SLNO N/A
- Revenue Next Year
- CRTO $7.82
- SLNO N/A
- P/E Ratio
- CRTO $19.28
- SLNO N/A
- Revenue Growth
- CRTO N/A
- SLNO N/A
- 52 Week Low
- CRTO $33.15
- SLNO $36.61
- 52 Week High
- CRTO $49.93
- SLNO $73.97
- Technical
- Relative Strength Index (RSI)
- CRTO 38.19
- SLNO 84.44
- Support Level
- CRTO $34.53
- SLNO $48.29
- Resistance Level
- CRTO $38.48
- SLNO $51.88
- Average True Range (ATR)
- CRTO 1.42
- SLNO 3.03
- MACD
- CRTO 0.16
- SLNO 2.32
- Stochastic Oscillator
- CRTO 17.70
- SLNO 93.61
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.